When was Gencove founded?

Gencove was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Gencove located?

Gencove is headquartered in New York City, United States.

How many employees does Gencove have?

As of Mar 31, 2026, the latest employee count at Gencove is 15.

Is Gencove a funded company?

Gencove is a funded company, having raised a total of $16.2M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 11, 2017.

When was the latest funding round of Gencove?

Gencove's latest funding was a $***** Series A round on Oct 26, 2021, with participation from 5 investors.

Where does Gencove rank among its competitors?

Gencove ranks 45th amongst 764 active competitors, of which 94 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of Gencove?

Gencove's top competitors include Tessera Therapeutics, Strand Life Sciences and Hexagon Bio. Among them, SeqOne secured the most recent funding round in May, 2025.

Gencove - 2026 Company Profile, Team, Funding & Competitors

Company Details

Gencove, formerly seeq.io, is a personal genomics service. The company's focus is centered around its app-based data reporting system. The client purchases a kit that is used to transport saliva to the company's labs, where it undergoes ultra-low coverage whole genome sequencing. The data is analyzed and shared with the client through the app, which allows the client to explore ancestry and information about the oral microbiome with friends easily. The client can also download the raw sequencing data for analysis at their end. The company also gives the clients, the possibility to participate in population genetics studies, in addition to designing and executing population genomics research programs for clients.

Website: gencove.com
Social
Email ID: *****@gencove.com

Key Metrics

Founded Year

2016

Location

New York City, United States

Stage

Series A

Total Funding

$16.2M in 5 rounds

Latest Funding Round

Series A, Oct 26, 2021, $*****

Investors

Spero Ventures & 11 more

Ranked

45^th among 764 active competitors

Employee Count

15 as on Mar 31, 2026

Similar Companies

Strand Life Sciences & 869 more

View Gencove's full profile

Gencove has raised a total funding of $16.2M over 5 rounds. Its first funding round was on Jul 11, 2017. Its latest funding round was a Series A round on Oct 26, 2021 for $*****. 5 investors participated in its latest round. Gencove has 12 institutional investors.

Here is the list of recent funding rounds of Gencove:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 26, 2021	2640357	Series A	5853684	5024486	7777786	8127008
Apr 19, 2021	2990452	Series A	4788824	7298066	3287538	9289800
May 01, 2019	7877115	Grant (prize money)	9496870	7244110	4667873	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Gencove's funding rounds and investors

The founders of Gencove are Kaja Wasik and Tomaz Berisa.

Here are the details of Gencove's key team members:

Kaja Wasik: Co-Founder of Gencove.
Contact Info: 1 email address
Tomaz Berisa: Co-Founder of Gencove.
Contact Info: 1 email address

View details of Gencove's Founder profiles and Board Members

Gencove's employee count trend

Gencove has 15 employees as of Mar 26. Here is Gencove's employee count trend over the years:

Uncover Gencove's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Gencove include Tessera Therapeutics, Strand Life Sciences and Hexagon Bio. Here is the list of Top 10 competitors of Gencove, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	ADIA, Temasek & 22 others	64/100
2nd	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 91 others	64/100
3rd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, 8VC & 10 others	63/100
4th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	61/100
5th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	OurCrowd, ALIVE & 5 others	61/100
6th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	F-Prime Capital, Domain Associates & 5 others	60/100
7th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Kenson Ventures, Ampersand Capital & 5 others	59/100
8th	Omniome 2013, San Diego (United States), Acquired	Provider of genome sequencing platform	$160M	Decheng Capital, DCVC & 12 others	59/100
9th	deCODE Genetics 1996, Reykjavik (Iceland), Acquired	Provider of a bioinformatics platform for genetic analysis	-	Hercules Capital, Tekla Capital Management ... & 10 others	58/100
10th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Omnes Capital, Elaia & 7 others	55/100
45th	Gencove 2016, New York City (United States), Series A	Cloud platform for personal genomics	$16.2M	SV Angel, Alexandria & 10 others	43/100